• Technology
  • DuplexSeq™ Kits
    • AML Assay
    • Mutagenesis Assay
    • Custom
  • Resources
    • Publications
    • Posters
    • Safety
    • Patents
  • Company
    • Our Team
    • Careers
    • Events
    • News
    • Investors
  • Contact

On-demand webinar

The future of mutagenesis testing is here.

Watch now
TwinStrand Biosciences
  • Technology
  • DuplexSeq™ Kits
    • AML Assay
    • Mutagenesis Assay
    • Custom
  • Resources
    • Publications
    • Posters
    • Safety
    • Patents
  • Company
    • Our Team
    • Careers
    • Events
    • News
    • Investors
  • Contact

Legal Notices – Patents

  • Website Terms of Use
  • Privacy Policy
  • Patents
  • Trademarks
  • Product and Services Terms and Conditions
  • Financial Conflict of Interest Policy

Last modified: August 2, 2021

 

This page is intended to serve as notice under 35 U.S.C. § 287(a) that TwinStrand products and services, including but not limited to TwinStrand Duplex Sequencing™ Kits, the TwinStrand DuplexSeq™ Bioinformatics Platform, and/or methods of using the foregoing, may be covered by one or more of the following U.S. patent(s), which are owned by or exclusively licensed to TwinStrand Biosciences, Inc. (“TwinStrand”):

 

U.S. Patent Numbers:

US 9,752,188

US 10,287,631

US 10,370,713

US 10,385,393

US 10,570,451

US 9,970,054

US 10,604,804

US 10,689,699

US 10,689,700

US 10,711,304

US 10,752,951

US 10,760,127

US 10,870,882

US 11,047,006

 

Foreign Patent Numbers:

EP 2828218

EP 2855707

CA 2,872,141

AU 2013267609


Additional patents pending in the U.S. and in several foreign jurisdictions.

 

Back To Top

 

TwinStrand Biosciences, Inc.
3131 Elliott Ave, Suite 750 • Seattle, WA 98121 • USA
+1 (877) 202-TWIN

 

For Research Use Only. Not for use in diagnostic procedures.

©2022 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners.  Legal Notices

  




American Society of Hematology (ASH)

December 5-8, 2020 – Virtual

 

Poster Presentation

 

“Duplex Sequencing with Patient-Specific Hybrid Capture Panels Reveals Ultra-Low Frequency Measurable Residual Disease in Pediatric Acute Myeloid Leukemia”

 

Presented by Jake Higgins, Senior Scientist – December 6, 2020 7:00 a.m.-3:30 p.m. PST

 

Conference Website

 

Society of Toxicology (SOT)

March 10-14, 2019 – Baltimore, MD

 

Poster Presentations

 

 

View Poster

 

 

Conference Website

 

AACR Annual Meeting – San Diego, CA

March 29-April 3, 2019

 

Poster Presentations

 

 

View Poster

 

 

View Poster

Presentations by CEO Jesse Salk, MD, PhD – AGBT 2020

Ultra-Sensitive Residual Leukemia Detection with Patient-Specific Dupex Sequencing